FORMULATION AND IN VITRO EVALUATION OF BROMOCRIPTINE MESYLATE AS FAST DISSOLVING ORAL FILM
Objective: The aim of this study was to formulate and in vitro evaluate fast dissolving oral film of practically insoluble bromocriptine mesylate to enhance its solubility and to improve its oral bioavailability by avoiding first pass effect as well as to produce an immediate release action of the drug from the film for an efficient management of diabetes mellitus type II in addition to an improvement of the patient compliance to this patient-friendly dosage form.
Methods: The films were prepared by the solvent casting method using hydroxypropyl methylcellulose of grades (E3, E5, E15), polyvinyl alcohol (PVA), pectin and gelatin as film-forming polymers in addition to polyethene glycol 400 (PEG400), propylene glycol (PG) and glycerin were used as a plasticizer. Poloxamer 407 was used as a surfactant, sodium saccharin as a sweetening agent, citric acid as a saliva stimulating agent, vanilla as a flavouring agent and crospovidone as a super disintegrant. The prepared films then tested for physical characterization, thickness, weight uniformity, mechanical characteristics (folding endurance, tensile strength, percent elongation and Young's modulus), surface pH, in vitro disintegration time, drug content and an in vitro drug release.
Results: Films were found to be satisfactory when evaluated for physical characterization, thickness, weight uniformity, mechanical tests, in vitro disintegration time, folding endurance, drug content and an in vitro drug release. The surface pH of all the films was found to be neutral or minor change. Films in vitro drug release studies were also done using USP dissolution apparatus type II (paddle type). The in vitro drug release profile in the optimized formulation F14 was gave 86.8 % of drug released at 2 min. The optimized formulation F14 was also showed satisfactory pH (6.2Â±0.2), drug content (99.2Â±0.5%), the disintegration time of 9.2Â±0.1 seconds and the time needed for 80% of medication to be released (T80 %) was 1.35 minute.
Conclusion: The bromocriptine mesylate fast dissolving oral film was formulated. The given film disintegrates within nine seconds which release the drug rapidly and gives an action.
2. Joshua JM, Hari R, Jyothish FK, Surendran SA. Fast dissolving oral thin films: an effective dosage form for quick release. Int J Pharm Sci Rev Res 2016;38:282-9.
3. Patil P, Shrivastava SK. Fast dissolving oral films: an innovative drug delivery system. Int J Sci Res 2014;3:2088-93.
4. Singh G, Saini S, Gill NS. Oral fast dissolving films: an innovative drug delivery system. Int J Univ Pharm Biosci 2014;3:163-77.
5. Krishna KR. Formulation and evaluation of oral fast dissolving film of atazanavir. Indo Am J Pharm Sci 2014;1:182-90.
6. Mahde BW, Ghareeb MM, Abdulrasool AA. Formulation and evaluation of gastroretentive floating tablet of bromocriptine mesilate. Int J Pharm Pharm Sci 2013;5:361-5.
7. Bhattacharjee A. Formulation and evaluation of immediate release tablets of bromocriptine mesylate by direct compression method. Indo Am J Pharm Res 2013;3:2841-5.â€
8. Shivaprasad C, Kalra S. Bromocriptine in type 2 diabetes mellitus. Indian J Endo Meta 2011;15 Suppl 1:S17â€“S24.
9. Noor AH, Khalil YI. Formulation and evaluation of felodipine orodispersible films. Pharm Glob 2015;6:1-16.
10. Bhikshapathi DVRN, Madhuri VD, Rajesham VV, Suthakaran R. Preparation and evaluation of fast dissolving oral film containing naratriptan HCl. Am J Pharm Tech Res 2014;4:799-812.
11. Sri KV, Rohini P, Reddy GK. Montelukast sodium oral thin films: formulation and in vitro evaluation. Asian J Pharm Clin Res 2012;5:266-70.
12. Raju S, Reddy PS, Kumar VA, Deepthi A, Reddy KS, Reddy PM, et al. Flash release oral films of metoclopramide hydrochloride for pediatric use: Formulation and in vitro evaluation. J Chem Pharm Res 2011;3:636-46.
13. United States Pharmacopoeia. The USP Convention; 2011. p. 34.
14. Sultana F, Arafat M, Pathan SI. Preparation and evaluation of fast dissolving oral thin film of caffeine. Int J Pharm Biol Sci 2013;3:153-61.
15. Pathan A, Gupta MK, Jain NK, Dubey A, Agrawal A. Formulation and evaluation of fast dissolving oral film of promethazine hydrochloride using a different surfactant. J Inno Pharm Bio Sci 2016;3:74-84.
16. Maheswari KM, Devineni PK, Deekonda S, Shaik S, Uppala NP, Nalluri BN, et al. Development and evaluation of mouth dissolving films of amlodipine besylate for enhanced therapeutic efficacy. J Pharm 2014;3:1-10.
17. Nalluri BN, Sravani B, Anusha VS, Sribramhini R, Maheswari KM. Development and evaluation of mouth dissolving films of sumatriptan succinate for better therapeutic efficacy. J Appl Pharm Sci 2013;3:161-6.
18. Vijayakumar S, Gavaskar B. Overview on fast dissolving films. Int J Pharm Pharm Sci 2010;2:293-317.
19. Rani JL, Abbulu K. Formulation, and evaluation of fast dissolving delivery system of saxagliptin. Int J Chem Pharm Sci 2014;2:862-9.
20. Remidi T, Prasanna K, Mohanty D, Spandana M, Ratnapuram RS. Formulation and in vitro evaluation of oral thin film of mirtazapine. Int J Invent Pharm Sci 2014;2:844-9.
21. Preis M, Pein M, Breitkreutz J. Development of a taste-masked orodispersible film containing dimenhydrinate. Pharmaceutics 2012;4:551-62.
22. Geedi V, Roy SD, Reddy PV. Formulation and evaluation of fast dissolving oral films of zolmitriptan by natural polymers. Int J Adv Pharm 2014;4:57-63.
23. Pragati B, Divya J, Archana D. Fast dissolving films of chlorpheniramine maleate. Am J Pharm Tech Res 2014;4:207-14.
24. Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 2007;8:127-33.
25. Kumar SK, Nagabhushanam MV, Rao KRSS, Bhikshapathi DVRN. Formulation development and in vivo evaluation of zolmitriptan oral dissolving films. Int J Pharm Bio Sci 2013;4:638-54.
26. Sagban TH, Ismail YK. Formulation and evaluation of orodispersible film of sildenafil citrate. Int J Pharm Pharm Sci 2014;6:81-6.
27. Tomar A, Sharma K. Formulation and evaluation of fast dissolving film of dicyclomine as a potential route of buccal delivery. Int J Drug Dev Res 2012;4:408-17.
28. Chinnala KM, Panigrahy RN, Bantu R, Sravanthi B. Formulation and evaluation of mouth dissolving films containing tizanidine hydrochloride. Int J Pharm Res Health Sci 2015;3:621-62.
29. Chauhan SS, Lin S, Madan PL. Preparation and evaluation of nicotine hydrogen tartrate fast dissolving films for smoking cessation. Asian J Pharm Sci 2012;7:181-92.
30. Pradhan R, Budhathoki U, Thapa P. Formulation of one-day release tablet of indomethacin based on HPMC-manitol. J Sci Eng Technol Kathmandu University 2008;1:55-67.
31. Manmat GS, Milind LS, Santosh PA, Disouza JI. Fast dissolving HPMC E5 based oral film for rapid absorption of metoprolol tartrate. Eur J Pharm Med Res 2014;1:75-91.
32. Doddayya H, Patil SS, Sree GR, Waseem H, Udupi RH. Design and in vitro evaluation of fast dissolving films containing HP ÃŸ CD inclusion complexes of lamotrigine. J Drug Delivery Ther 2014;4:99-106.
33. Sapkal NP, Kilor VA, Daud AS, Bonde MN. Development of fast dissolving oral thin films of ambroxol hydrochloride: effect of formulation variables. J Adv Pharm Res 2011;2:102-9.
34. Kaza R, Elevate PR, Ravouru N. Design, and characterization of fast dissolving films of valsartan. Turkish J Pharm Sci 2014;11:175-84.
35. Trivedi J, Patel J, Patel U. Formulation development and evaluation of fast dissolving film of cinnarizine. Int J Pharm Biol 2014;3:639-52.
36. Salman ZD, Marie NK, Alabbassi MG, Ghareeb MM. In vitro/in vivo evaluation and bioavailability study of amitriptyline hydrochloride from the optimized oral fast dissolving films. UK J Pharm Biol 2014;2:32-42.
37. Ali MS, Vijendar C, Kumar S, Krishnaveni J. Formulation and evaluation of fast dissolving oral films of diazepam. J Pharmacovigilance 2016;4:210-5.
38. Choudhary DR, Patel VA, Chhalotiya UK, Patel HV, Kundawala AJ. Formulation and evaluation of fast dissolving film of levocetirizine dihydrochloride using different grades of methocel. J Pharm Res 2011;4:2919-24.
39. Abd-Alhammid SN, Saleeh HH. Formulation and evaluation of flurbiprofen oral film. Iraqi J Pharm Sci 2014;23:53-9.
40. Jadhav YG, Galgatte UC, Chaudhari PD. Challenges in formulation development of fast dissolving oral film. Indo Am J Pharm Res 2013;3:6391-407.
41. Chauhan SS, Lin S, Madan PL. Preparation and evaluation of nicotine hydrogen tartrate fast dissolving films for smoking cessation. Asian J Pharm Sci 2012;7:181-92.
42. Miller Dave A., McGinty James W, Aqueous polymeric film coating, in Augsburger Larry L, Hoag Stephen W. eds. Pharmaceutical dosage forms: Tablets. 3rd ed. New York: Information Health Care; 2008.
43. Gupta AM, Gupta V, Bansal P, Singh R, Singh AK. Recent trends of fast dissolving tablet-an overview of formulation technology. Int J Pharm Biol Arch 2010;1:1-10.
44. Heer DA, Aggarwal G, Hari Kumar SL. Development of fast dissolving oral films and tablet of cinnarizine: effect of superdisintegrants. Int J Pharm Pharm Sci 2014;6:186-91.
45. Archana G, Raju PN, Reddy GN. Formulation and in vitro evaluation of atazanavir oral disintegrating tablets. Asian J Pharm Clin Res 2014;7:184-8.
46. Mohanachandran PS, Sindhumol PG, Kiran TS. Superdisintegrant: an overview. Int J Pharm Sci Rev Res 2011;6:22.
47. Robert MS, Frances XW, David JK. Spectrometric identification of organic compounds. 7th ed. New York: John Wiley; 2005.
48. Reddy PB, Varma MM, Betha S, Basava DR, Mecha R, Ratna JV. Formulation, development and characterization of chlorpheniramine maleate mouth dissolving films. Pelagia Res Lib 2013;4:1-9.